The incidence of allergies in Germany has risen rapidly since the 1970s. Information on the burden and costs of allergic diseases, epidemiology and medication use in Germany Therapy allergen ordinance (Therapieallergeneverordnung) Social Security Statute Book (Sozialgesetzbuch) Impact of Air POLLution on Asthma and Rhinitis Nasal fixed combination combining Azelastine and Fluticasone MAladies Chroniques pour un Vieillissement Actif (Fighting chronic diseases for active and healthy ageing) Grading of Recommendations-Assessment, Development and Evaluation
On AHA European Innovation Partnership on Active and Healthy AgeingĮuropean Institute for Innovation and Technology German Institute for Medical Documentation and Information (Deutsches Institut für Medizinische Dokumentation und Information)Įuropean Academy for Allergy and Clinical Immunology
ARIA MEANING TRIAL
Placebo-controlled randomized clinical trial
German Allergy and Asthma Association (Deutscher Allergie- und Asthmabund) Pharmaceutical Directive (Arzneimittelrichtlinie)Īllergic Rhinitis and its Impact on Asthma German Medicinal Products Act (Arzneimittelgesetz) Integrated care pathways for airway diseases Medical Association of German Allergists (Ärzteverband deutscher Allergologen) Discussion: A comprehensive ICP guideline can reflect real-life care better than traditional guideline models. It includes the views of patients and other healthcare providers. Results: The present ICP (integrated care pathway) guideline covers key areas of the care of AR patients with and without asthma. In the present work, these integrated care pathways have been adapted to the German situation and health system. In collaboration with other international initiatives, national associations and patient organizations in the field of allergies and respiratory diseases, real-life integrated care pathways have been developed for a digitally assisted, integrative, individualized treatment of allergic rhinitis (AR) with comorbid asthma. Methods: ARIA serves to improve the care of patients with allergies and chronic respiratory diseases. The ARIA (Allergic Rhinitis and its Impact on Asthma) initiative develops internationally applicable guidelines for allergic respiratory diseases. Integrated care pathways are needed to enable comprehensive care within the national health systems. The resulting allergic diseases are leading to significant costs for health care and social systems. Papadopoulos, 45 Sanna Toppila-Salmi, 46 Thomas Werfel, 47 and Jean Bousquet 34, 35, 48, 49īackground: The number of patients affected by allergies is increasing worldwide. Fokkens, 40 Eckard Hamelmann, 41 Marek Jutel, 42 Désirée Larenas-Linnemann, 43 Joaquim Mullol, 44 Nikolaos G. Casale, 38 Wienczylawa Czarlewski, 39 Wytske J. Canonica, 36 Victoria Cardona, 37 Thomas B. Kopp, 16 Vera Mahler, 17 Hans Merk, 18 Norbert Mülleneisen, 19 Katja Nemat, 20 Uta Rabe, 21 Johannes Ring, 22 Joachim Saloga, 23 Wolfgang Schlenter, 24 Carsten Schmidt-Weber, 25 Holger Seyfarth, 26 Annette Sperl, 1 Thomas Spindler, 27 Petra Staubach, 23 Sebastian Strieth, 28 Regina Treudler, 29 Christian Vogelberg, 30 Andrea Wallrafen, 31 Wolfgang Wehrmann, 32 Holger Wrede, 33 Torsten Zuberbier, 34 Anna Bedbrook, 35 Giorgio W. Ludger Klimek, 1 Claus Bachert, 2 Oliver Pfaar, 3 Sven Becker, 4 Thomas Bieber, 5 Randolph Brehler, 6 Roland Buhl, 7 Ingrid Casper, 1 Adam Chaker, 8 Wolfgang Czech, 9 Jörg Fischer, 10 Thomas Fuchs, 11 Michael Gerstlauer, 12 Karl Hörmann, 13 Thilo Jakob, 14 Kirsten Jung, 15 Matthias V.
0 kommentar(er)
